Monday - Friday, 10:00 - 11:00 SIN/HK | 0400 - 05:00 CET In this video Lihan Zhou, CEO of Mirxes, talks about the biotech company's path to profitability, He also addresses opportunities from Mirxes' ...
Mirxes, a spin-off of Singapore’s Agency for Science, Technology and Research, plans to make Hong Kong the base for its push into the larger Greater Bay Area (GBA) market, company co-founder and chief ...
The latest announcement is out from Mirxes Holding Company Limited ( (HK:2629)). Mirxes Holding Company Limited has issued a supplemental announcement on resumption guidance and continued suspension ...
BIOTECH startup MiRXES has signed a memorandum of understanding (MOU) with a clinical research project for the discovery and validation of a test for the early detection of cancer. The project, called ...
Mirxes Holding (SEHK:2629) has quietly attracted attention after its recent price swings, with the stock moving up 2% in a single day and surging almost 27% over the past month. While there has not ...
SINGAPORE / ACCESSWIRE / March 9, 2020 / The ncRNA (non-coding RNA) is one kind of molecular substances that has been discovered not so long ago but existing in all organisms. This molecule can affect ...
The company also has denied any formal plans to go public via a de-SPAC in the US. Singapore biotechnology startup Mirxes has denied that it has any formal IPO plans in Singapore, contradicting an ...
The work of three researchers originally from Singapore’s Agency for Science, Technology and Research (A*STAR) and the National University of Singapore (NUS) has changed the face of preventive health ...
HONG KONG – Singapore has produced its first billion-dollar biotechnology start-up, 25 years after it began formally building its life sciences industry. Mirxes, which invented and produces the ...
SINGAPORE - Singapore biotech firm Mirxes launched its initial public offering (IPO) in Hong Kong on May 15, aiming to raise HK$1.09 billion (S$181 million) to support stronger growth in the coming ...
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
MIRXES-B (02629.HK) 0.000 (0.000%) announced that the company's auditor requires more time to assess certain prepayments made ...